CClinicalTrials.gg
CompletedNCT015372373DATGvsCTUpdated Nov 25, 2014

Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation

An observational study in Atrial Fibrillation and Arrhythmia, sponsored by Steward St. Elizabeth's Medical Center of Boston, Inc.. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-11-25.

Sponsored by Steward St. Elizabeth's Medical Center of Boston, Inc. · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
37
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare rotational angiography (3DATG technology)intra-procedure (during the ablation procedure) with CT (x-ray) pre-procedure (before the ablation procedure) fusion to create an anatomical picture of a heart to help adequately guide an ablation procedure for patients with arrhythmias.

Read the detailed description

Rotational angiography (or three dimensional arteriography or "3DATG") is a new tool used to guide atrial fibrillation (AF) ablation. The current approach to imaging for AF ablation involves obtaining a computer tomography (CT) angiogram of the atrium pre-procedure and combining it with an electro-anatomical map, a process called merging or overlay. The investigators propose to investigate the quality of the 3DATG as a replacement for the CT in obtaining a left atrial angiogram (to guide AF ablation).

All imaging modalities to be evaluated in this study are currently used in clinical practice. They are not experimental methods. The goal is to compare two modalities that have never been directly compared before. The CT angiography utilizes a standard CT scanner and intravenously injected contrast agent to visualize the left atrium. While the 3DATG is a method that achieves similar results to a CT scanner, the difference is that the 3DATG images are acquired by rotating the X-ray source around the patient on a C-arm instead of a dedicated CT scanner.

60 participants will be consented and randomized to either pre-procedure CT or intra-procedure 3DATG. Scheduled participants will undergo sedation and catheter instrumentation as appropriate. CT anatomy data will then be merged with the live X-ray via the EP Navigator system in standard fashion or the patient will be prepped for appropriate 3DATG anatomy data acquisition and merged with the EP Navigator system. The EP Navigator system will then be used to send either data to NavX or CARTO to create the intended electro-anatomical map.

Using the CT or 3DATG acquired electro-anatomical map, the ablation procedure will be conducted in the same way as would the local practice and standard of care for any patient not participating in the study.

The ablation procedure and the sites of ablation lesions will be tagged on the 3D overlaid anatomy in the same fashion as previously published and all participants will be followed as routine at a 1 month and 3 month follow up.

02

Conditions studied

  • Atrial Fibrillation
  • Arrhythmia

Browse trials for

Keywords

  • Atrial Fibrillation
  • Catheter-based ablation
  • Pulmonary vein isolation
  • Electro-anatomical mapping
  • Rotational angiography
03

In context

Atrial Fibrillation

3,870 studies on the registry are indexed under Atrial Fibrillation; 923 are open to participants now.

This study's enrollment of 37 is below the median of 300 across 1,362 observational studies indexed under Atrial Fibrillation.

Browse Atrial Fibrillation studies →

Lead sponsor

Steward St. Elizabeth's Medical Center of Boston, Inc. is the lead sponsor of 23 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients undergoing a clinically indicated left-sided ablation procedure for atrial fibrillation who therefore satisfy conventional criteria for catheter ablation.

Inclusion criteria

  • All patients undergoing a clinically indicated left-sided ablation procedure for atrial fibrillation

Exclusion criteria

Exclusion Criteria:

  • Patients not willing or able to provide consent to participate or already involved in another clinical trial.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
37 participants (actual)

Groups and cohorts

  • intra-procedure 3DATG

    Patients who will undergo intra-procedure 3DATG rotational angiography to guide their ablation procedure

  • pre-procedure CT

    Patients who will undergo pre-procedure CT scan to guide their ablation procedure

06

What researchers measure

Primary outcomes

  1. Evidence of procedural success for an ablation procedure using 3DATG fusion

    Case report forms were created to capture intraprocedure data (i.e.noticeable map drift) of the maps created and used to create ablation lesions. Procedure user's overall clinical evaluation (i.e.feedback) and experience (i.e. radiation time, number of mapping points collected per map, mapping time) will also be collected and analyzed. And patients will be followed as routine for overall disease evaluation (i.e. ECG and patient reported symptoms) within 6 months from the procedure.

    Time frame: within 6 months

Secondary outcomes

  1. Overall radiation exposure to the patient

    Case report forms were created to capture the exposure each cohort of patients will be subjected to.

    Time frame: Pre-procedure (for CT cohort) to end of procedure

07

Study locations

2 sites
  • Holy Cross Hospital
    Fort Lauderdale, Florida 33308, United States
  • St. Elizabeth's Medical Center
    Brighton, Massachusetts 02135, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01537237
Lead sponsor
Steward St. Elizabeth's Medical Center of Boston, Inc.
Responsible party
Sponsor
First posted
Feb 23, 2012
Start date
Aug 2011
Primary completion
Aug 2013
Completion
Nov 2014
Last update
Nov 25, 2014

Study contacts

Michael V Orlov, MD, PhD
principal investigator · St. Elizabeth's Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion